
Entos Pharmaceuticals Partners with Alberta Cell Therapy Manufacturing and the Ottawa Hospital Research Institute to Manufacture and Ready its COVID-19 DNA Vaccine for Clinical Trials
Entos Pharmaceuticals (Entos), a biotechnology company developing genetic medicines with its Fusogenix nucleic acid delivery platform, is excited to work with Alberta Cell Therapy Manufacturing and The Ottawa Hospital’s Biotherapeutics Manufacturing Centre to manufacture and ready doses of Entos’ made-in-Canada Covigenix VAX-001 vaccine for upcoming clinical trials at the Canadian […]